Royal Oak, MINCT06150599Now EnrollingIRB Ready

Chronic Pelvic Pain Syndrome Clinical Trial in Royal Oak, MI

Access cutting-edge chronic pelvic pain syndrome treatment through this clinical trial at a research site in Royal Oak. Study-provided care at no cost to qualified participants.

Sponsored by Corewell Health East

Quick Self-Assessment

See if you qualify for this Royal Oak location

Preparing your pre-screening questions…

Expert Care in Royal Oak

Access chronic pelvic pain syndrome specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic pelvic pain syndrome treatment provided free

Apply for This Royal Oak Location

Check if you qualify for this chronic pelvic pain syndrome clinical trial in Royal Oak, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Royal Oak

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Royal Oak site if eligible
  4. 4Begin participation

About This Chronic Pelvic Pain Syndrome Study in Royal Oak

Sacral neuromodulation (SNM) is a safe, effective, and minimally invasive FDA approved treatment for urinary and fecal incontinence, urinary frequency, urgency, and urinary retention. In this study we are assessing the effectiveness of sacral neuromodulation in women with suffering from chronic pelvic pain (CPP), through a single device implant procedure.

Sponsor: Corewell Health East

Who Can Participate

Inclusion Criteria

Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Female, aged 22-70
Chronic pelvic pain (= pain below umbilicus) score of 4 or greater on 10-point VAS, present for 6 months or greater (screening patient)
Failed at least 1 or more conservative treatments (e.g. pelvic floor physical therapy, biofeedback, behavioral modification, oral pharmacotherapy, bladder instillations)
No changes to current regimen of medications for their pelvic pain for \> 4 weeks prior to screening
For females of reproductive potential: use of highly effective contraception (e.g. licensed hormonal or barrier methods), for at least 1 month prior to screening and agreement to use such a method during study participation
Participant agrees not to start any new treatment interventions for CPP prior to Visit 4 (Primary Endpoint)

Exclusion Criteria

History of any active pelvic cancer
Any significant medical condition that is likely to interfere with study procedures, device operation, or likely to confound evaluation of study endpoints
Concurrent pain management strategies within the past 3 months that may interfere or mask study intervention (e.g. pelvic floor physical therapy, shockwave therapy, trigger point injections, bladder instillations)
Any psychiatric or personality disorder at the discretion of the study physician. This does not include depression or generalized anxiety disorders that are stable.
Current symptomatic urinary tract infection (UTI) or more than 6 UTIs in past year
Severe or uncontrolled diabetes (A1C \> 7, documented in the last 3 months) or diabetes with peripheral nerve involvement
Interstitial cystitis diagnosis with Hunner's lesions as this is a severe inflammatory bladder condition that can only be treated with eradication of the lesions or a cystectomy. SNM would be be expected to help for IC with Hunner's lesions
Previously implanted with a sacral neuromodulation device or participated in a sacral neuromodulation trial
Subject with documented history of allergy to titanium, zirconia, polyurethane, epoxy, or silicone
Implantation of spinal cord stimulator and/or drug delivery pumps, whether turned on or off
A female who is breastfeeding or of child-bearing potential with a positive urine pregnancy test or not using adequate contraception
Current treatment for active malignancy (skin cancers excluded)
Patients with spinal pathology that could confound study results. This may include participants with cauda equina syndrome, spinal stenosis, neurogenic claudication, lumbar radiculopathy, patients with primary complaints of leg pain with numbness and or weakness, patients with a primary pain compliant that is vascular in origin, clinical evidence of progressive neurologic pathology, mechanical instability or other spinal pathology that requires surgical intervention, spine or visceral pain secondary to neoplasm, visceral pain in the upper abdomen rather than the pelvis, current diagnosis of fibromyalgia participants with significant cognitive impairment, participants with a condition currently requiring or likely to require use of diathermy or MRI or history of any other condition that in the opinion of the investigator could put the participant at risk or interfere with study results interpretation. (screening patient).
Participants involved in ongoing litigation and or injury claims or workers compensation claims.
Participation in a current clinical trial or within the preceding 30 days Note- to preserve the scientific integrity of the study some criteria have been omitted from this posting. All eligibility criteria will be listed at the close of the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Royal Oak?

Yes, this clinical trial (NCT06150599) has an active research site in Royal Oak, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Pelvic Pain Syndrome Treatment Options in Royal Oak, MI

If you're searching for chronic pelvic pain syndrome treatment options in Royal Oak, MI, this clinical trial (NCT06150599) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Royal Oak research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic pelvic pain syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic pelvic pain syndrome clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Royal Oak, MI

See all pulmonary embolism clinical trials recruiting in Royal Oak — not just this study.

Browse Pulmonary Embolism Trials in Royal Oak →

Browse More Trials by Condition

Pulmonary Embolism TrialsChronic Pain TrialsInterstitial Cystitis TrialsEndometriosis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Royal Oak?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Royal Oak, MI